About this trial
This effectiveness trial will investigate if patients with hip dysplasia randomised to exercise and patient education have a different mean change in self-reported pain measured by the Copenhagen Hip and Groin Outcome Score (HAGOS) compared with those randomised to usual care over a six-month follow-up period.
Participating patients will be allocated to either exercise and patient education or usual care. Alongside this, a health-economic study and a process-evaluation study will be conducted.
Eligibility criteria
Qualifiers
Radiographically verified hip dysplasia by a Wiberg's centre edge (CE) angle of 10-25 degrees and an acetabular Index (AI) angle >10 degrees
Hip and/or groin pain as primary pain for at least three months
Candidate for periacetabular osteotomy (PAO) but unwilling to undergo PAO, or on a waiting list for surgery (PAO) for 12 months or longer
Not candidate for PAO (negative impingement test, BMI >25, hip osteoarthritis, age >45 years or reduced hip range of motion)
Disqualifiers
Self-reported pain score >80 points measured with Copenhagen Hip and Groin outcome score
Any major planned surgery (i.e. arthroplastic surgery or discectomy surgery)
BMI >35
Acetabular retroversion defined by crossover sign and posterior wall sign
Trial design
Treatments tested in this trial
- Exercise and patient education
- Usual Care
Treatment groups
Sponsors and collaborators
University of Aarhus
Lead sponsor
Research Unit for General Practice, Aarhus University
Collaborator
VIA University College
Collaborator
Copenhagen University Hospital, Hvidovre
Collaborator
Defactum, Central Denmark Region
Collaborator